Vogt / Gaillard / Green

Erschienen: 29.07.2025

Organoids for Personalised Cancer Medicine

A Vision Assessment of an Emerging Health Technology

Springer

ISBN 978-3-031-85534-4

Standardpreis


42,79 €

lieferbar ca. 10 Tage als Sonderdruck ohne Rückgaberecht

Preisangaben inkl. MwSt. Abhängig von der Lieferadresse kann die MwSt. an der Kasse variieren. Weitere Informationen

Bibliografische Daten

Fachbuch

Buch. Softcover

2025

1 s/w-Abbildung, 11 Farbabbildungen.

In englischer Sprache

Umfang: ix, 126 S.

Format (B x L): 15,5 x 23,5 cm

Verlag: Springer

ISBN: 978-3-031-85534-4

Weiterführende bibliografische Daten

Das Werk ist Teil der Reihe: SpringerBriefs in Philosophy

Produktbeschreibung

This open access book builds on and updates work performed in the HYBRIDA project, funded by the EU to develop an ethical framework for organoid research. Organoids are three-dimensional stem cell constructs that mimic organs of the body or tumours. Patient-derived organoids are envisioned to be grown from individual patients’ tumours and used to tailor the most effective and safest treatments in a new form of personalized medicine. This text offers a critical assessment of this vision from the perspective of philosophy of medicine. The authors present a tailored “vision assessment”, presented as examples of methodological development, and applied to objects. They first analyse and describe the vision of using organoids for personalized cancer medicine, then critically evaluate this vision and finally comment on ethical implications of the epistemological issues and how to handle them. The authors further draw on sources for empirical inquiries. This book presents an exercise in health technology assessment conducted by philosophers. Its core readership are philosophers of medicine and bioethicists interested in personalized medicine and stem cell research.

Autorinnen und Autoren

Kundeninformationen

Addresses emerging technology with significant implications for medical research and practice Shows how visions and emerging technology can be assessed systematically Provides the first comprehensive review of the field of patient-derived organoids for cancer This book is open access, which means that you have free and unlimited access

Produktsicherheit

Hersteller

Springer Nature Customer Service Center GmbH

ProductSafety@springernature.com

Topseller & Empfehlungen für Sie

Ihre zuletzt angesehenen Produkte

Rezensionen

Dieses Set enthält folgende Produkte:
    Auch in folgendem Set erhältlich:

    • nach oben

      Ihre Daten werden geladen ...